23 October 2026
MiniMed Vivera Data and Twiist Type 2 Clearance
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
About
Automated insulin delivery keeps moving toward systems that ask less of the people using them. In this episode of Diabetes Dialogue, Diana Isaacs, PharmD, and Natalie Bellini, DNP, look at two recent developments and talk through what they mean for clinical practice.
In this episode:
First-in-human results for the MiniMed Vivera algorithm, and how it performed when participants skipped meal announcements
What the trial population can and can’t tell us about real-world patients
The FDA clearance of the twiist AID system for adults with insulin-treated type 2 diabetes
How the twiist algorithm differs from other systems, and tips for setting it up
Where reduced-burden AID could go next